Randomized clinical trials in hepatocellular carcinoma and biliary cancer.
Primary hepatocellular carcinoma (HCC) remains among the most common malignancies in the world. Many of the advances in the treatment of this disease have come from combinations of early detection in endemic areas, improved radiologic evaluation in defining extent of disease, an increased use of nonsurgical treatment and improvements in surgical technique.
Martin
Robert C G
RC
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. martinr@mskcc.org
Jarnagin
William R
WR
D001661:Biliary Tract Neoplasms / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008495:Medical Oncology; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic